Bristol Heart Institute, University of Bristol, School of Clinical Sciences, Bristol, United Kingdom.
Bristol Heart Institute, University of Bristol, School of Clinical Sciences, Bristol, United Kingdom.
J Thorac Cardiovasc Surg. 2016 Nov;152(5):1321-1330.e12. doi: 10.1016/j.jtcvs.2016.06.038. Epub 2016 Jun 29.
We conducted a single-center analysis on short-term outcomes and long-term survival in actively treated diabetic patients undergoing off-pump coronary artery bypass versus on-pump coronary artery bypass surgery.
The final population consisted of 2450 patients with actively treated diabetes (mean age, 66 ± 9 years; female/male 545/1905, 22%). Of those, 1493 subjects were orally treated and 1011 subjects were taking insulin. Off-pump coronary artery bypass and on-pump coronary artery bypass were performed in 1253 and 1197 patients, respectively. Propensity score matching was used to compare the 2 matched groups.
When compared with on-pump coronary artery bypass, off-pump coronary artery bypass was associated with a significant risk reduction for postoperative cerebrovascular accident (odds ratio, 0.49; 95% confidence interval [CI], 0.25-0.99; P = .04), need for postoperative intra-aortic balloon pump (odds ratio, 0.48; 95% CI, 0.30-0.77; P = .002), and reexploration for bleeding (odds ratio, 0.55; 95% CI, 0.33-0.94; P = .02). Off-pump coronary artery bypass did not significantly affect early (hazard ratio [HR], 1.32; 95% CI, 0.73-2.40; P = .36) and late (HR, 1.08; 95% CI, 0.92-1.28; P = .32) mortality. However, off-pump coronary artery bypass with incomplete revascularization was associated with reduced survival when compared with off-pump coronary artery bypass with complete revascularization (HR, 1.82; 95% CI, 1.34-2.46; P = .0002) and on-pump coronary artery bypass with complete revascularization (HR, 1.83; 95% CI, 1.36-2.47; P < .0001).
Off-pump coronary artery bypass is a safe and feasible option for diabetic patients with multivessel disease, reduces the incidence of early complications including postoperative cerebrovascular events, and provides excellent long-term survival similar to on-pump coronary artery bypass surgery in case of complete revascularization.
我们对行非体外循环冠状动脉旁路移植术(off-pump coronary artery bypass,OPCAB)与体外循环冠状动脉旁路移植术(on-pump coronary artery bypass,ONCAB)的积极治疗糖尿病患者的短期结局和长期生存进行了单中心分析。
最终纳入了 2450 例积极治疗糖尿病患者(平均年龄 66±9 岁;女性/男性 545/1905,22%)。其中,1493 例接受口服药物治疗,1011 例接受胰岛素治疗。1253 例患者接受 OPCAB,1197 例患者接受 ONCAB。采用倾向评分匹配比较 2 个匹配组。
与 ONCAB 相比,OPCAB 术后发生脑血管意外的风险显著降低(比值比,0.49;95%置信区间 [CI],0.25-0.99;P=0.04),需要术后主动脉内球囊反搏的风险降低(比值比,0.48;95%CI,0.30-0.77;P=0.002),需要再次探查出血的风险降低(比值比,0.55;95%CI,0.33-0.94;P=0.02)。OPCAB 对早期(风险比 [HR],1.32;95%CI,0.73-2.40;P=0.36)和晚期(HR,1.08;95%CI,0.92-1.28;P=0.32)死亡率无显著影响。然而,与完全血运重建的 OPCAB 相比,不完全血运重建的 OPCAB 与降低的生存率相关(HR,1.82;95%CI,1.34-2.46;P=0.0002),与完全血运重建的 ONCAB 相比(HR,1.83;95%CI,1.36-2.47;P<0.0001)。
对于多支血管病变的糖尿病患者,OPCAB 是一种安全可行的选择,可降低术后脑血管事件等早期并发症的发生率,并在完全血运重建的情况下提供与 ONCAB 手术相似的优异长期生存率。